IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor α promoter

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5667-5674

  Mariner, Jennifer M ^a   Mamane, Yael ^a   Hiscott, John ^a   Waldmann, Thomas A ^a   Azimi, Nazli ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; TAX PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; GENE ACTIVATION; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T CELL LEUKEMIA; VIROGENESIS;

EID: 0036604305     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5667     Document Type: Article

References (43)

1. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
2. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor
3. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
4. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15
5. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor
6. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor
7. Functional characterization of the human interleukin 15 receptor α chain and close linkage of IL-15RA and IL-2RA genes
8. Interleukin-15: A novel anabolic cytokine for skeletal muscle
9. Differential effects of interleukin-15 and interleukin-2 on differentiation of bi-potential T/natural killer progenitor cells
10. Potential role for interleukin-15 in the regulation of human natural killer cell survival
11. Ontogeny of NK cells and the bone marrow microenvironment: Where does IL-15 fit in?
12. Requirement for IRF-I in the microenvironment supporting development of natural killer cells
13. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
14. Deregulated T cell activation and autoimmunity in mice lacking IL-2 receptor β
15. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
16. + memory T cells by opposing cytokines
17. Interleukin-15 protects from lethal apoptosis in vivo
18. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
19. + T cells in vivo by IL-15
20. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells
21. IL-15 receptor maintains lymphoid homeostais by supporting lymphocyte homing and proliferation
22. Reversible effects on natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
23. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site
24. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15Rβ receptor
25. Human T cell lymphotropic virus type 1 Tax activates IL-15Rα gene expression through an NF-κB site
26. Characterization of cellular factors that interact with the human T-cell leukemia virus type 1 p40x-responsive 21-base pair sequence
27. The pX protein of HTLV-1 is a transcriptional activator of its long terminal repeats
28. Activation of interleukin 2 and interleukin 2 receptor (Tac), promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I
29. Transactivation of Interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy
30. Induction of Interleukin 2 receptor gene expression by p40x encoded by human T cell leukemia virus type I
31. c-fos promoter trans-activation by the tax 1 protein of human T-cell leukemia virus type I
32. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB
33. IRF family of transcription factors as regulators of host defense
34. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes
35. Activation and regulation of interferon regulatory factor 4 in HTLV type I-infected T lymphocytes
36. Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated
37. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3
38. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52
39. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7
40. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes
41. Viral activation of interleukin-15 (IL-15): Characterization of a virus-inducible element in the IL-15 promoter region
42. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA
43. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: Modulation of interferon-regulated gene expression by Rel/nuclear factor κB